![Adrian Quartel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Quartel
Keine laufenden Positionen mehr
Vermögen: 139 428 $ am 30.06.2026
Profil
Adrian Quartel worked at BioMarin Pharmaceutical, Inc. from 2016 to 2020, serving as Head-Medical Affairs from 2017 to 2020.
From 2020 to 2022, worked at Adamas Pharmaceuticals LLC as Chief Medical Officer.
From 2022 to 2023, worked at Acer Therapeutics, Inc. as Chief Medical Officer.
Education includes a doctorate from Erasmus University Rotterdam and a graduate degree from The Royal College of Physicians.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.01.2026 | 9’723 ( 0.02% ) | 139 428 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Adrian Quartel
| Unternehmen | Position | Ende |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.07.2026 |
| ACER THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| ADAMAS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2022 |
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
Ausbildung von Adrian Quartel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Wählen Sie MarketScreener 
